Thermage is a medical device company that is dedicated to developing and commercializing advanced radio frequency (RF) based technologies for dermatology and plastic surgery applications. Since 1995, Thermage has filed for over 30 patents related to its RF technology. The introductory device, the ThermaCool TC™ System, combines the known reliability of RF tissue heating with Thermage patented innovations that enable nonablative thermal modification of skin and underlying tissue.
(NASDAQ: THRM)
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 05/02/02 | Series B | 4.5M | Unknown |
People
Marti Morfitt (Board Member)
Cathy McCarthy (Board Member)
Mark Sieczkarek (Board Member)
William Brodie (VP Sales)
Gary Wilson (VP Sales International)
News
Solta Medical takes $17.2M for skin repair services
January 11, 2010 5:29 pm
Solta Medical, developer of treatments for wrinkled, aging and sun-damaged skin, has brought in $17.2 million in a sale of… Continue reading ⟩
Primaeva Medical, latest co. to remove those old wrinkles, raises $7M
December 13, 2006 2:41 pm
Primaeva Medical Inc., (no Website yet) a Palo Alto start-up developing a skin tightening and rejuvenation dermatological device, has raised… Continue reading ⟩
Thermage, the anti-wrinkle company, suffers IPO bumbs — prices below forecast
November 10, 2006 4:11 pm
Thermage, the Hayward maker of devices to treat wrinkles, priced six million common shares in its IPO at $7 per… Continue reading ⟩